Gamolenic Acid
CAS 506-26-3
Gamolenic Acid (CAS 506-26-3) is a Phase 3 pharmaceutical compound with 6 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | AC50 | 27363.475 nM | 32 | - |
| - | Potency | 36816.02285714286 nM | 28 | - |
| - | IC50 | 14061.25 nM | 8 | - |
| - | EC50 | 4620 nM | 1 | - |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 Enzyme |
IC50 | 4.85 | - | Homo sapiens |
| Peroxisome proliferator-activated receptor alpha Nuclear hormone receptor |
IC50 | 6.57 | - | Homo sapiens |
| Peroxisome proliferator-activated receptor gamma Nuclear hormone receptor |
IC50 | 5.66 | - | Homo sapiens |
| Peroxisome proliferator-activated receptor delta Nuclear hormone receptor |
IC50 | 6.12 | - | Homo sapiens |
| Free fatty acid receptor 1 GPCR |
EC50 | 5.33 | - | Homo sapiens |
| Tissue factor Membrane receptor |
IC50 | 4.52 | - | Homo sapiens |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Gamolenic Acid used for in pharmaceutical contexts?
Gamolenic Acid (CAS 506-26-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Gamolenic Acid?
No adverse-event association or SIDER side-effect rows are rendered for Gamolenic Acid in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Gamolenic Acid also used in cosmetics?
No same-CAS cosmetics profile is rendered from the ingredients-table cross-reference for Gamolenic Acid.
What clinical phase is Gamolenic Acid in?
Gamolenic Acid is rendered with ChEMBL max phase 3.
What bioactivity targets are documented for Gamolenic Acid?
Gamolenic Acid has 10 bioactivity rows in this page query. Rendered target entries include 3-oxo-5-alpha-steroid 4-dehydrogenase 2, Peroxisome proliferator-activated receptor alpha, Peroxisome proliferator-activated receptor gamma, Peroxisome proliferator-activated receptor delta, Free fatty acid receptor 1.